Trading Statement

Synexus Clinical Research PLC
04 October 2006


Synexus Clinical Research plc ("the Company")

Trading update

Synexus Clinical Research plc, the international organisation providing patient
recruitment to the global clinical trials industry, confirms that it will
release its interim results for the six months ended 30 September 2006 in the
week commencing 4 December 2006. Prior to entering its close period, the Company
today issues a trading update.

Trading in the first half of the year has met management's expectations with
early contributions from the Company's acquisitions in Poland and Hungary. The
board has been very encouraged by the buoyancy of enquiries during the period.
The Company continues to pursue actively its stated strategy of overseas
expansion and identification of potential acquisition opportunities is ongoing.

The Directors remain confident about the prospects for the Company for the
remainder of the financial year.


Press enquiries

Synexus Clinical Research plc                    Tel: [phone]
Michael Fort, Chief Executive

Biddicks - Financial Public Relations            Tel: [phone]
Zoe Biddick




                      This information is provided by RNS
            The company news service from the London Stock Exchange